Russian Federation: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in the Russian Federation

The Russian prophylactic medicaments containing insulin market reached $X in 2022, increasing by 3% against the previous year. The market value increased at an average annual rate of +1.2% over the period from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. As a result, consumption reached the peak level of $X. From 2016 to 2022, the growth of the market remained at a somewhat lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in the Russian Federation

In value terms, prophylactic medicaments containing insulin production rose modestly to $X in 2022 estimated in export price. In general, production, however, continues to indicate a relatively flat trend pattern. The growth pace was the most rapid in 2015 with an increase of 28% against the previous year. As a result, production attained the peak level of $X. From 2016 to 2022, production growth remained at a lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from the Russian Federation

In 2022, approx. X tons of medicaments containing insulin but not antibiotics in measured doses were exported from Russia; picking up by 48% compared with 2021 figures. Over the period under review, exports continue to indicate significant growth. The pace of growth was the most pronounced in 2018 with an increase of 1,591% against the previous year. Over the period under review, the exports attained the maximum in 2022 and are likely to continue growth in the immediate term.

In value terms, prophylactic medicaments containing insulin exports declined markedly to $X in 2022. In general, exports recorded significant growth. The growth pace was the most rapid in 2018 with an increase of 2,183%. As a result, the exports attained the peak of $X. From 2019 to 2022, the growth of the exports failed to regain momentum.

Exports by Country

Azerbaijan (X tons), Uzbekistan (X tons) and Ukraine (X tons) were the main destinations of prophylactic medicaments containing insulin exports from Russia, with a combined 94% share of total exports. Kazakhstan lagged somewhat behind, comprising a further 5.7%.

From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by Kazakhstan (with a CAGR of +272.0%), while the other leaders experienced more modest paces of growth.

In value terms, Azerbaijan ($X) emerged as the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Russia, comprising 72% of total exports. The second position in the ranking was held by Kazakhstan ($X), with a 12% share of total exports. It was followed by Ukraine, with an 11% share.

From 2012 to 2022, the average annual growth rate of value to Azerbaijan totaled +123.5%. Exports to the other major destinations recorded the following average annual rates of exports growth: Kazakhstan (+296.5% per year) and Ukraine (+53.2% per year).

Export Prices by Country

The average prophylactic medicaments containing insulin export price stood at $X per ton in 2022, with a decrease of -43.9% against the previous year. Overall, the export price recorded a drastic downturn. The growth pace was the most rapid in 2020 an increase of 78% against the previous year. Over the period under review, the average export prices attained the maximum at $X per ton in 2013; however, from 2014 to 2022, the export prices remained at a lower figure.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Kazakhstan ($X per ton), while the average price for exports to Uzbekistan ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Uzbekistan (+22.4%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into the Russian Federation

In 2022, approx. X tons of medicaments containing insulin but not antibiotics in measured doses were imported into Russia; reducing by -9.6% compared with 2021. Over the period under review, imports saw a relatively flat trend pattern. The most prominent rate of growth was recorded in 2013 with an increase of 46%. As a result, imports attained the peak of X tons. From 2014 to 2022, the growth of imports remained at a lower figure.

In value terms, prophylactic medicaments containing insulin imports reduced remarkably to $X in 2022. In general, imports faced a deep contraction. The most prominent rate of growth was recorded in 2021 when imports increased by 64% against the previous year. Over the period under review, imports reached the peak figure at $X in 2013; however, from 2014 to 2022, imports stood at a somewhat lower figure.

Imports by Country

Italy (X tons), Denmark (X tons) and France (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to Russia, together accounting for 100% of total imports.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by Italy (with a CAGR of 0.0%), while imports for the other leaders experienced a decline.

In value terms, Denmark ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics in measured doses to Russia, comprising 77% of total imports. The second position in the ranking was held by Italy ($X), with a 13% share of total imports.

From 2012 to 2022, the average annual growth rate of value from Denmark totaled -6.6%. The remaining supplying countries recorded the following average annual rates of imports growth: Italy (0.0% per year) and France (-20.4% per year).

Import Prices by Country

The average prophylactic medicaments containing insulin import price stood at $X per ton in 2022, reducing by -11% against the previous year. Over the period under review, the import price saw a drastic downturn. The most prominent rate of growth was recorded in 2021 an increase of 33% against the previous year. The import price peaked at $X per ton in 2012; however, from 2013 to 2022, import prices stood at a somewhat lower figure.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Denmark ($X per ton), while the price for Italy ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Denmark (-3.3%).

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :